Apical surface expression of aspartic protease Plasmepsin 4, a potential transmission-blocking target of the plasmodium ookinete.
To invade its definitive host, the mosquito, the malaria parasite must cross the midgut peritrophic matrix that is composed of chitin cross-linked by chitin-binding proteins and then develop into an oocyst on the midgut basal lamina. Previous evidence indicates that Plasmodium ookinete-secreted chitinase is important in midgut invasion. The mechanistic role of other ookinete-secreted enzymes in midgut invasion has not been previously examined. De novo mass spectrometry sequencing of a protein obtained by benzamidine affinity column of Plasmodium gallinaceum ookinete axenic culture supernatant demonstrated the presence of an ookinete-secreted plasmepsin, an aspartic protease previously only known to be present in the digestive vacuole of asexual stage malaria parasites. This plasmepsin, the ortholog of Plasmodium falciparum plasmepsin 4, was designated PgPM4. PgPM4 and PgCHT2 (the P. gallinaceum ortholog of P. falciparum chitinase PfCHT1) are both localized on the ookinete apical surface, and both are present in micronemes. Aspartic protease inhibitors (peptidomimetic and natural product), calpain inhibitors, and anti-PgPM4 monoclonal antibodies significantly reduced parasite infectivity for mosquitoes. These results suggest that plasmepsin 4, previously known only to function in the digestive vacuole of asexual blood stage Plasmodium, plays a role in how the ookinete interacts with the mosquito midgut interactions as it becomes an oocyst. These data are the first to delineate a role for an aspartic protease in mediating Plasmodium invasion of the mosquito and demonstrate the potential for plasmepsin 4 as a malaria transmission-blocking vaccine target.
Li
Fengwu
F
Division of Infectious Diseases, Department of Medicine, University of California San Diego School of Medicine, La Jolla, California 92093, USA.
Patra
Kailash P
KP
Yowell
Charles A
CA
Dame
John B
JB
Chin
Karen
K
Vinetz
Joseph M
JM
D000330:Aedes / Q000469:parasitology; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D000953:Antigens, Protozoan / Q000276:immunology* / Q000378:metabolism; D000954:Antigens, Surface / Q000276:immunology / Q000378:metabolism; D016282:Aspartic Acid Endopeptidases / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D002645:Chickens; D004926:Escherichia coli / Q000235:genetics; D007422:Intestines / Q000469:parasitology; D017780:Malaria Vaccines / Q000276:immunology* / Q000378:metabolism; D008289:Malaria, Avian / Q000469:parasitology / Q000517:prevention & control* / Q000635:transmission; D016253:Microscopy, Immunoelectron; D033661:Oocysts / Q000378:metabolism / Q000648:ultrastructure; D010964:Plasmodium gallinaceum / Q000201:enzymology* / Q000254:growth & development; D011994:Recombinant Proteins / Q000235:genetics / Q000276:immunology / Q000378:metabolism
D000911:Antibodies, Monoclonal; D000953:Antigens, Protozoan; D000954:Antigens, Surface; D017780:Malaria Vaccines; D011994:Recombinant Proteins; D016282:Aspartic Acid Endopeptidases; C089643:plasmepsin